Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update
Cristiano Chaves(Queen's University), Jaime E. C. Hallak(Conselho Nacional de Desenvolvimento Científico e Tecnológico), João Paulo Sousa(Universidade de Ribeirão Preto), Antônio Waldo Zuardi(Universidade de São Paulo), Serdar Dursun(Centre for Addiction and Mental Health), Clarissa Trzesniak(Conselho Nacional de Desenvolvimento Científico e Tecnológico), J.A.S. Crippa(National Council for Scientific and Technological Development), Cristiane Reberte de Marque(Universidade de Ribeirão Preto)
Cited by 75
Related Papers
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
|Brazilian Journal of Psychiatry|2015|484